• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Global Health R&D
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Global Health R&D
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!

Charak Foundation — Ramatroban Clinical Trial

  • Portfolio Area: Human Health and Wellbeing
  • Focus Area: Scientific Research
  • Organization Name: Charak Foundation
  • Amount: $195,600

  • Award Date: March 2022

Table of Contents

    Open Philanthropy recommended a grant of $195,600 to the Charak Foundation to fund the initial stages of a clinical trial of ramatroban for the suppression of life-threatening symptoms of COVID-19 infections.

    Ramatroban is a pill approved for sale and use against allergic rhinitis in Japan, and has been used for over twenty years without incident. The trial will involve the recruitment of people who have been admitted to hospitals with COVID-19. The treatment cohort will be followed for 4-6 months to assess outcomes that include mortality, hypoxemia, length of hospital stay, cytopenia, pulmonary fibrosis, and symptoms related to “long COVID.”

    This falls within our focus area of scientific research, and specifically within our interest in advancing human health and wellbeing.

    Related Items

    • Human Health and Wellbeing

      University of Georgia — Malaria Research (2023)

      Open Philanthropy recommended a grant of $192,925 over three years to the University of Georgia to support research on Plasmodium vivax, which is one of the parasite species...

      Read more
    • Human Health and Wellbeing

      Washington University in St. Louis — Omega-3 Trial for Pregnant Women

      Open Philanthropy recommended a grant of $1,500,000 over three years to Washington University in St. Louis to support a randomized controlled trial in Sierra Leone, led by Dr. Mark...

      Read more
    • Human Health and Wellbeing

      Foundation for Professional Development Fund — Syphilis Genome Sequencing

      Open Philanthropy recommended a grant of $229,080 over three years to the Foundation for Professional Development Fund to support their collaboration with the University of Southern California and...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    • Stay Updated
    Mailing Address
    Open Philanthropy
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    © Open Philanthropy 2022 Except where otherwise noted, this work is licensed under a Creative Commons Attribution-Noncommercial 4.0 International License. If you'd like to translate this content into another language, please get in touch!